118 related articles for article (PubMed ID: 19072366)
1. Telbivudine in the treatment of chronic hepatitis B.
Hadziyannis SJ; Vassilopoulos D
Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):13-22. PubMed ID: 19072366
[TBL] [Abstract][Full Text] [Related]
2. Telbivudine in the treatment of chronic hepatitis B.
Nash K
Adv Ther; 2009 Feb; 26(2):155-69. PubMed ID: 19225726
[TBL] [Abstract][Full Text] [Related]
3. Telbivudine for the management of chronic hepatitis B virus infection.
Matthews SJ
Clin Ther; 2007 Dec; 29(12):2635-53. PubMed ID: 18201580
[TBL] [Abstract][Full Text] [Related]
4. Telbivudine versus lamivudine in patients with chronic hepatitis B.
Lai CL; Gane E; Liaw YF; Hsu CW; Thongsawat S; Wang Y; Chen Y; Heathcote EJ; Rasenack J; Bzowej N; Naoumov NV; Di Bisceglie AM; Zeuzem S; Moon YM; Goodman Z; Chao G; Constance BF; Brown NA;
N Engl J Med; 2007 Dec; 357(25):2576-88. PubMed ID: 18094378
[TBL] [Abstract][Full Text] [Related]
5. Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.
Hou J; Yin YK; Xu D; Tan D; Niu J; Zhou X; Wang Y; Zhu L; He Y; Ren H; Wan M; Chen C; Wu S; Chen Y; Xu J; Wang Q; Wei L; Chao G; Constance BF; Harb G; Brown NA; Jia J
Hepatology; 2008 Feb; 47(2):447-54. PubMed ID: 18080339
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic hepatitis B: focus on telbivudine.
Lui YY; Chan HL
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):259-68. PubMed ID: 19344240
[TBL] [Abstract][Full Text] [Related]
7. Telbivudine: an effective anti-HBV drug for chronic hepatitis B patients with early on-treatment responses.
Hann HW
Expert Opin Pharmacother; 2010 Sep; 11(13):2243-9. PubMed ID: 20698726
[TBL] [Abstract][Full Text] [Related]
8. Safety evaluation of telbivudine.
But DY; Yuen MF; Fung J; Lai CL
Expert Opin Drug Saf; 2010 Sep; 9(5):821-9. PubMed ID: 20662545
[TBL] [Abstract][Full Text] [Related]
9. Telbivudine: a novel nucleoside analog for chronic hepatitis B.
Kim JW; Park SH; Louie SG
Ann Pharmacother; 2006 Mar; 40(3):472-8. PubMed ID: 16507625
[TBL] [Abstract][Full Text] [Related]
10. Treatment of HBeAg-positive chronic hepatitis B with nucleos(t)ide analogues.
Leung N
Liver Int; 2011 Jan; 31 Suppl 1():85-9. PubMed ID: 21205143
[TBL] [Abstract][Full Text] [Related]
11. On-treatment monitoring of chronic hepatitis B virus infection: an Asian-Pacific perspective.
Chien RN
J Gastroenterol Hepatol; 2010 May; 25(5):852-7. PubMed ID: 20546437
[TBL] [Abstract][Full Text] [Related]
12. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
[TBL] [Abstract][Full Text] [Related]
13. Telbivudine: an upcoming agent for chronic hepatitis B.
Yuen MF; Lai CL
Expert Rev Anti Infect Ther; 2005 Aug; 3(4):489-94. PubMed ID: 16107194
[TBL] [Abstract][Full Text] [Related]
14. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
Han GR; Cao MK; Zhao W; Jiang HX; Wang CM; Bai SF; Yue X; Wang GJ; Tang X; Fang ZX
J Hepatol; 2011 Dec; 55(6):1215-21. PubMed ID: 21703206
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
16. Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides.
Nguyen MH; Keeffe EB
J Viral Hepat; 2009 Mar; 16(3):149-55. PubMed ID: 19236641
[TBL] [Abstract][Full Text] [Related]
17. Telbivudine for the treatment of chronic hepatitis B infection.
Hartwell D; Jones J; Harris P; Cooper K
Health Technol Assess; 2009 Oct; 13 Suppl 3():23-30. PubMed ID: 19846025
[TBL] [Abstract][Full Text] [Related]
18. A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B.
Lai CL; Leung N; Teo EK; Tong M; Wong F; Hann HW; Han S; Poynard T; Myers M; Chao G; Lloyd D; Brown NA;
Gastroenterology; 2005 Aug; 129(2):528-36. PubMed ID: 16083710
[TBL] [Abstract][Full Text] [Related]
19. Therapy of chronic hepatitis B: focus on telbivudine.
Gaeta GB; Stornaiuolo G
Dig Liver Dis; 2007 Nov; 39 Suppl 3():S372-8. PubMed ID: 18063258
[TBL] [Abstract][Full Text] [Related]
20. A dose-finding study of once-daily oral telbivudine in HBeAg-positive patients with chronic hepatitis B virus infection.
Lai CL; Lim SG; Brown NA; Zhou XJ; Lloyd DM; Lee YM; Yuen MF; Chao GC; Myers MW
Hepatology; 2004 Sep; 40(3):719-26. PubMed ID: 15349912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
